Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor against dexamethasone suppression of fungicidal activity for aspergillus fumigatus conidia

Medical Mycology

Volumn 39, Issue 6, 2001, Pages 509-515

  Brummer, E ^a,b   Maqbool, A ^c,d   Stevens, D A ^a  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^b CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c STANFORD UNIVERSITY   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aspergillus; Corticosteroids; GM CSF; Macrophages

Indexed keywords

CONCANAVALIN A; CORTICOSTEROID DERIVATIVE; DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL CELL; ARTICLE; ASPERGILLUS FUMIGATUS; ASSAY; CELL KILLING; CONTROLLED STUDY; CULTURE MEDIUM; DEXAMETHASONE SUPPRESSION TEST; FUNGICIDAL ACTIVITY; FUNGUS CULTURE; FUNGUS SPORE; IN VITRO STUDY; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PREMEDICATION; PROTECTION; SPLEEN CELL;

ANIMALIA; ASPERGILLUS; ASPERGILLUS FUMIGATUS; FUNGI; MURINAE;

EID: 0035662682     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/mmy.39.6.509.515     Document Type: Article

References (30)

1. Anderson RJ. Schaffer LA. Olin DB. Eickhoff C. Infectious risk factors in the immunosuppressed host. Am .1 Mal 1973: 54: 453-460.
2. Gustal'son TL. Schaffner W, Lavely GB. Stratum CW. Johnson HK. Hutcherson RH. Invasive aspergillosis in renal transplant recipients: correlation with corticosteriod therapy. J Inject Dis 1983: 148: 230-238.
3. Walsh TJ. Mendelsohn G. Invasive aspergillosis complicating Cushing's syndrome. Arch Intern Met! 1981: 141: 1227-1228.
4. Graham S, Tucker WS. Opportunistic infections in endogenous Cushing's syndrome. Ann Intern Med 1984: 101: 334-338.
5. Schaffner A. Therapeutic concentrations of glucosteroids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma Interferon. JClin Invest 1985:76: 1755-1764.
6. Roilides E. Blake C. Holmes A. Pizzo PA. Walsh TJ. Granulocyte-macrophage colony-stimulating factor and inlerferon-gamma prevent dexamethasone-induced immunosuppression of antifungal monocyle activity against Aspergillus fiimigatiis hyphae.JMeet Vet Mycol 1996: 34: 63-69.
7. Michaliszyn E, Sénéchal S, Martel P. deRepentigny L. Lack of involvement of nitric oxide in killing Aspergillns fumiganis conidia hy pulmonary alveolar macrophages. Infect Immun 1995: 63: 2075-2078.
8. Rohertson MD. Kcrr KM. Seaton A. Killing of Axpergillnx fumigatus spores hy human lung macrophages: a paradoxical effect of hcat-lahile scrum components.JMed Vet Mycol 1989: 27: 295-302.
9. Sugar AM. Brummer F., Stevens DA. Murine pulmonary macrophages: evaluation of lung lavage fluids, miniaturized monolayers. and eandidacidal activity. Am Rev Rexpir Dis 1983: 127: 110-112.
10. Washhurn RCi. (iallin .11. Bennett .IE. Oxidative killing of Aspergillitx fmitigdiits hy parallel MPO-dependent and independent pathways. Infect Immun 1987: 55: 2088-2092.
11. Brummer H. Morozumi PA. Vo PT. Stevens DA. Protection against pulmonary blastomycosis: adoptive transfer with T lymphocytes, hut not serum, from resistant mice. Cell Imimuiol 1982: 73: 349-359.
12. Schaffner A, Douglas H. Braude A. Selective protection against conidia hy mononuclear and against mycelia hy polymorphonuclear phagocytes in resistance to Axpcrgillux. .1 Clin Invent 1982: 69: 617-631.
13. Levitz SM. Diamond RD. Mechanisms of resistance of A.tpei'ffillux hiinigiititu conidia to killing hy neutrophils in vitro. J Inject Dis 1985: 152: 33-43.
14. Schaffner A. Douglas H. Braude AI. Davis CE. Killing of Axpcrgillux spores depends on the anatomical source. Infect bnintii) 1983: 42: 1109-1115.
15. Kozel TR, Wilson MA. Farrell TP. Levitz SM. Activation of C3 and hinding to Aspcrgillus fitmigunis conidia and hyphae. Infect Immun 1989; 57: 3412-3417.
16. Condino-Neto A. Whitney C. Newhurger PE. Dexamethasone hut not indomethacin inhibits human phagocyte nicotinamidc adenine dinucleolide phosphate oxidase activity hy down regulating expression of genes encoding oxidase components. JImmunol 1998: 161:4960-4967.
17. Natarajan l", Randhavva N. Brummer E, Stevens DA. Effect of granulocyte-macrophage colony-stimulating factor on eandidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole. JMeil Microbiol 1998:47:359-363.
18. Vora S. Punmella N. Brummer E. Stevens DA. Activity of voriconazole. a new triazole. combined with neutrophils or monocyles against Cuml'ula tilhicunx: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colonystimulating factor. Anlimicrtih Agents Cliemollter 1998; 42: 907-910.
19. Vora S. Chauhan S. Brummer E. Stevens DA. Activity of voriconazole combined with neutrophils or monocytes against Axpergilliis fumigutiix: effect of granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor. Aniiinicmb Agents Cliemother 1998; 42: 2299-2303.
20. Lim TK. Chen G-H, McDonald RA. Toews GB. Granulocytemacrophage colony-stimulating factor overrides the immunosuppressive function of corticosteroids on rat pulmonary dentritic cells. Stem Cells 1996:14: 292-299.
21. Munck A, Mendel DB. Smith LI, Orti E. Glucocorticoid receptors and actions. Am Rev Rexpir Dis 1990:141:S2-S10.
22. Payvar F. Wränge O. ("arlstedt-Duke J. Ohret S. Gustal'ason JA, Yamamoto KR. Purified glucocorticoid receptors hind selectively in vitro to a cloned DNA fragment whose transcription is regulated by glucocorticoids in vivo. Proc Mat! Acini Sei USA 1981: 78: 6628-6632.
23. Auphan N, Di Donate JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kB activity through induction of IkB synthesis. Science 1995; 270: 286-290.
24. Rosen RL, Winestock KD, Chen G. Liu X, Henninghausen L, Finbloom DS. Granulocyte-macrophage colony-stimulating factor preferentially activates 94 kD STATSa and an 80 kD STATSa isoform in human blood monocytes. Blood 1996; 88: 1206-1214.
25. Al-Shami A, Mahanna W, Nacake PH. Granulocyte-macrophage colony-stimulating factor activated signaling pathways in human neutrophils. Selective activation of JAK2, STATSb, and STAT3. J Biol Chem 1998; 273: 1058-1063.
26. Linden M. Brattsand R. Effect of a corticosteroid, budenoside, on alveolar macrophage and blood monocyte secretion of cytokines: differential sensitivity of GM-CSF. IL-lβ and IL-6. Pul Pharmacol 1994; 7: 43-41.
27. Joyce DA, Steer JH, Abraham LJ. Glucocorticoid modulation of human monocyte/macrophage function: control of TNF-alpha secretion. Inflamm Res 1997; 46: 447-451.
28. Alwawi WY, Beyhum HN, Rahme AA, Rieder MJ. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leuk Biol 1996; 60: 563-572.
29. Moynihan JA. Callahan TA, Kelley SP, Campbell LM. Adrenal hormone modulation of type 1 and type 2 cytokine production by spleen cells: dexamethasone and dehydroepiandrosterone suppress interleukin-2, interleukin-4, and interferon gamma production in vitro. Cell Immunol 1998; 184: 58-64.
30. Ala-Aoukaty A, Giaid A, Sinoff C, Ho AD, Maghazachi AA. Priming effects of granulocyte-macrophage colony-stimulating factor are coupled to cholera toxin-sensitive guanine nucleotide binding protein in human T lymphocytes. Blood 1994; 83: 1299-1309.